Angelini Ventures invests in Serenis to continue scaling accessible and effective mental health care solutions 11/10/2022 Category: DIGITAL HEALTH
Angelini Ventures, Evotec and CDP Venture Capital launch translational partnership ‘Extend’ with leading Italian academic Institutions. 10/28/2022 Category: ACADEMIC PARTNERSHIPS
Pretzel Therapeutics, eyeing diseases caused by broken mitochondria, launches with $72.5 million 10/12/2022 Category: BIOTECH
World Mental Health Day 2022. Angelini Ventures along with Lumira Ventures through the Angelini-Lumira Biosciences Fund are proud to support the ongoing efforts to discover and develop novel therapies addressing unmet medical needs in mental health. 10/10/2022 Category: MENTAL HEALTH
Spotlight StoryDAMONA Pharmaceuticals is Shaping a New Path for Cognitive Care 10/10/2022 Category: MENTAL HEALTH
Argobio announces its launch with 50 M€ to create and develop pioneering biotech spinouts with the support of Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and the Institut Pasteur 6/3/2022 Category: INCUBATOR
Angelini Ventures